Locati L, Bottero D, Carriquiriborde F, López O, Pschunder B, Zurita E, Martin Aispuro P, Gaillard ME, Hozbor D.
Harnessing outer membrane vesicles derived from Bordetella pertussis to overcome key limitations of acellular pertussis vaccines.
Front. Immunol. Sec. Vaccines and Molecular Therapeutics. Volume 16 - 2025
doi: 10.3389/fimmu.2025.1655910

Rolando Ulloa-Gutierrez, Daniela Hozbor*, María L. Avila-Aguero, Gabriela Echániz-Aviles, Angela Gentile, Juan Pablo Torres Torretti, Ulrich Heininger, Rudzani Muloiwa, Carl Heinz Wirsing von König, Kevin Forsyth, Tina Q. Tan.
Country-specific data and priorities for pertussis in Latin America: recent findings from the Global Pertussis Initiative.
Open Forum Infect. Dis. Volume 12(5) - 2025
doi: 10.1093/ofid/ofaf154

Ramírez H, Vilte DA, Hozbor D, Zurita E, Bottero D, Casabonne MC, Cataldi ÁA, Wigdorovitz A, Larzábal M.
A Novel Vaccine for Bovine Diarrhea Complex Utilizing Recombinant Enterotoxigenic Escherichia coli and Salmonella Expressing Surface-Displayed Chimeric Antigens from Enterohemorrhagic Escherichia coli O157:H7.
Vaccines (Basel). Volume 13(2) - 2025
doi: 10.3390/vaccines13020124

Olson-Chen C, Swamy GK, Gonik B, Forsyth K, Heininger U, Hozbor D, von König CHW, Chitkara AJ, Top KA, Muloiwa R, van der Schyff M, Tan TQ.
The current state of pertussis vaccination in pregnancy around the world, with recommendations for improved care: Consensus statements from the Global Pertussis Initiative.
Int J Gynaecol Obstet. 2024
doi: 10.1002/ijgo.15311

Nguyen PNT, Heininger U, Muloiwa R, von König CHW, Hozbor D, Ong-Lim A, Tan TQ, Forsyth K.
Pertussis in Southeast Asia: country-level burden and recommendations from the Global Pertussis Initiative.
IJID Reg. Volume 14 - 2024
doi: 10.1016/j.ijregi.2024.100559

Rudi E, Gaillard ME, Bottero D, Ebensen T, Guzman CA, Hozbor D.
Mucosal Vaccination with Outer Membrane Vesicles Derived from Bordetella pertussis reduces Nasal Bacterial Colonization after experimental infection.
Front. Immunol. Sec. Vaccines and Molecular Therapeutics. Volume 15 - 2024
doi: 10.3389/fimmu.2024.1506638

Bernarda Pschunder, Lucia Locati, Oriana López, Pablo Martin Aispuro, Eugenia Zurita, Matthew Stuible, Yves Durocher, Daniela Hozbor.
Outer membrane vesicles derived from Bordetella pertussis are potent adjuvant that drive Th1-biased response.
Front. Immunol. Sec. Vaccines and Molecular Therapeutics. Volume 15 - 2024
doi: 10.3389/fimmu.2024.1387534

Pablo Martin Aispuro, Daniela Bottero, Maria Eugenia Zurita, Maria Emilia Gaillard, Daniela Flavia Hozbor*.
Bordetella pertussis responses in neonates mice born to animals primed with whole-cell versus acellular vaccine in infancy.
Front. Immunol. Sec. Vaccines and Molecular Therapeutics. Volume 14 - 2023
doi: 10.3389/fimmu.2023.1192119

Daniela Bottero, Erika Rudi, Pablo Martin Aispuro, Eugenia Zurita, Emilia Gaillard, Maria M. Gonzalez Lopez Ledesma, Juan Malito, Matthew Stuible, Nicolas Ambrosis, Yves Durocher, Andrea V. Gamarnik, Andrés Wigdorovitz, Daniela Hozbor*.
Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron.
Front. Immunol. Volume 14 - 2023
doi: 10.3389/fimmu.2023.1271209

Szwejser-Zawislak E, Wilk MM, Piszczek P, Krawczyk J, Wilczyńska D, Hozbor D.
Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity.
Vaccines (Basel). Volume 11(1) - 2022
doi: 10.3390/vaccines11010001

Abu-Raya B, Forsyth K, Halperin SA, Maertens K, Jones CE, Heininger U, Hozbor D, Wirsing von König CH, Chitkara AJ, Muloiwa R, Tan TQ.
Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative.
Vaccines (Basel). Volume 10(12) - 2022
doi: 10.3390/vaccines10121990

Chitkara AJ, Balasubramanian S, Choudhury J, Dash N, Forsyth K, Heininger U, Hozbor DF, Muloiwa R, Tan T, von König CHW.
Pertussis in India: Past, Present, and Future.
Indian J Pediatr. 2022
doi: 10.1007/s12098-022-04384-w

Rudi E, Martin Aispuro P, Zurita E, Gonzalez Lopez Ledesma MM, Bottero D, Malito J, Gabrielli M, Gaillard E, Stuible M, Durocher Y, Gamarnik AV, Wigdorovitz A, Hozbor D.
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concern.
Front. Immunol. Volume 13 - 2022
doi: 10.3389/fimmu.2022.1020159

Pascuale CA, Varese A, Ojeda DS, Pasinovich ME, Lopez L, Rossi AH, Rodriguez PE, Miglietta EA, Mazzitelli I, Di Diego Garcia F, Sanchez L, Rouco SO, Gonzalez Lopez Ledesma MM, Zurano JP, Mazzitelli B, Scruzzi G, Barbero P, Cardozo D, Gallego S, Borda M, Diaz M, Hozbor D, Docena G, Laino CH, Kreplak N, Pifano M, Barbas G, Rearte A, Vizzotti C, Castelli JM, Geffner J, Gamarnik AV.
Immunogenicity and reactogenicity of heterologous immunization against SARS-CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273.
Cell Rep. Med. Volume 3(8) - 2022
doi: 10.1016/j.xcrm.2022.100706

Jog P, Memon IA, Thisyakorn U, Hozbor D, Heininger U, von König CHW, Tan T; participants of the 2019 GPI Thailand Meeting.
Pertussis in Asia: Recent country-specific data and recommendations.
Vaccine. 2022
doi: 10.1016/j.vaccine.2021.12.004

Felipe Marceca, Luciana Rocha Viegas, Nicolas Pregi, María Gabriela Barbas, Daniela Hozbor, Adali Pecci, Roberto Etchenique.
Pool Strategy for Surveillance Testing of SARS-CoV-2.
Science Reviews - from the end of the world (ISSN 2683-9288). 2021

Ye Feng, Cheng-Hsun Chiu, Ulrich Heininger, Daniela Flavia Hozbor, Tina Tang, Carl-Heinz Wirsing von König.
Emerging macrolide resistance in Bordetella pertussis in mainland China: Findings and warning from the global pertussis initiative.
The Lancet Regional Health - Western Pacific. Volume 8 - 2021
doi: 10.1016/j.lanwpc.2021.100098

Nicolás Martín Ambrosis, Pablo Martin Aispuro, Keila Belhart, Daniela Bottero, Renée Leonor Crisp, María Virginia Dansey, Magali Gabrielli, Oscar Filevich, Valeria Genoud, Alejandra Giordano, Min Chih Lin, Anibal Roberto Lodeiro, Felipe Marceca, Nico Pregi, Federico Remes Lenicov, Luciana Rocha-Viegas, Erika Rudi, Guillermo Solovey, Maria Eugenia Zurita, Adali Pecci, Roberto Etchenique, Daniela F. Hozbor.
Active surveillance of asymptomatic, presymptomatic, and oligosymptomatic SARS-CoV-2-infected individuals in communities inhabiting closed or semi-closed institutions.
Front. Med. (Infectious Diseases – Surveillance, Prevention and Treatment). Volume 8 - 2021
doi: 10.3389/fmed.2021.640688

Toro R, Unzaga JM, Marquez G, Panei J, Bosch A, Docena G, Abba MC, Hozbor D.
La Universidad Pública y su rol en la pandemia COVID-19: laboratorios de diagnóstico al servicio de la red nacional de laboratorios de influenza y otros virus respiratorios.
Innovación y Desarrollo Tecnológico y Social. Volume 2(2):25–50 – 2020
doi: 10.24215/26838559e015

Maia L. Elizagaray, Marco Túlio R. Gomes, Erika S. Guimarães, Martín Rumbo, Daniela F. Hozbor, Sergio C. Oliveira, Griselda N. Moreno.
Canonical and non-canonical inflammasome activation by outer membrane vesicles derived from Bordetella pertussis.
Front. Immunol. 2020
doi: 10.3389/fimmu.2020.01879

Pablo Martin Aispuro, Nicolás Ambrosis, María Eugenia Zurita, María Emilia Gaillard, Daniela Bottero, Daniela Flavia Hozbor.
Use of a Neonatal-Mouse Model to Characterize Vaccines and Strategies for Overcoming the High Susceptibility and Severity of Pertussis in Early Life.
Front. Microbiol. Volume 11 – 2020
doi: 10.3389/fmicb.2020.00723

Camille Locht, Nicholas H. Carbonetti, James D. Cherry, F. Heath Damron, Kathryn M. Edwards, Rachel Fernandez, Eric T. Harvill, Daniela Hozbor, Kingston H. G. Mills, Maria Eugenia Rodriguez, Françoise Mascart.
Highlights of the 12th International Bordetella Symposium.
Clin. Infect. Dis. 2020
doi: 10.1093/cid/ciaa651

Amar J. Chitkara, Mónica Pujadas Ferrer, Kevin Forsyth, Nicole Guiso, Ulrich Heininger, Daniela Flavia Hozbor, Rudzani Muloiwa, Tina Q. Tan, Usa Thisyakorn, CH Wirsing von König.
Pertussis vaccination in mixed markets: recommendations from the Global Pertussis Initiative.
Int. J. Infect. Dis. Volume 96 – 2020
doi: 10.1016/j.ijid.2020.04.081

Carriquiriborde F, Regidor V, Aispuro PM, Magali G, Bartel E, Bottero D, Hozbor D.
Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina.
Emerg. Infect. Dis. Volume 25(11) – 2019
doi: 10.3201/eid2511.190329

Hozbor D.
New Pertussis Vaccines: A Need and a Challenge.
Adv. Exp. Med. Biol. 2019
doi: 10.1007/5584_2019_407

Hozbor D, Ulloa-Gutierrez R, Marino C, Wirsing von König CH, Tan T, Forsyth K.
Pertussis in Latin America: Recent epidemiological data presented at the 2017 Global Pertussis Initiative meeting.
Vaccine. Volume 37(36) – 2019
doi: 10.1016/j.vaccine.2019.07.007

Casabuono AC, Sisti F, Fernández J, Hozbor D, Couto AS.
Bordetella bronchiseptica Glycosyltransferase Core Mutants Trigger Changes in Lipid A Structure.
J. Am. Soc. Mass Spectrom. 2019
doi: 10.1007/s13361-019-02233-3

Maria Eugenia Zurita, Mieszko W. Wilk, Francisco Carriquiriborde, Erika Bartel, Griselda Noemi Moreno, Alicja Misiak, Kingston H.G. Mills, Daniela F. Hozbor.
A pertussis outer membrane vesicle-based vaccine induces lung-resident memory CD4 T cells and protection against Bordetella pertussis, including pertactin deficient strains.
Front. Cell. Infect. Microbiol. Volume 9 – 2019
doi: 10.3389/fcimb.2019.00125

Bergero PE, Fabricius G, Hozbor DF.
Non-mandatory immunization and its potential impact on pertussis epidemiology.
Arch. Argent. Pediatr. Volume 116(6):418–425 – 2018
doi: 10.5546/aap.2018.eng.418

Daniela Bottero, Maria Eugenia Zurita, Maria Emilia Gaillard, Francisco Carriquiriborde, Pablo Martin Aispuro, Maia L. Elizagaray, Erika Bartel, Celina E. Castuma, Daniela F. Hozbor.
Outer-membrane-vesicle–associated O antigen, a crucial component for protecting against Bordetella parapertussis infection.
Front. Immunol. 2018
doi: 10.3389/fimmu.2018.02501

G. Fabricius, P. Martin Aispuro, P. Bergero, D. Bottero, M. Gabrielli, D. Hozbor.
Pertussis epidemiology in Argentina: trends after the introduction of maternal immunization.
Epidemiol. Infect. Volume 146(7):858–866 – 2018
doi: 10.1017/S0950268818000808

Bottero D, Zurita ME, Gaillard ME, Bartel E, Vercellini C, Hozbor D.
Membrane vesicles derived from Bordetella bronchiseptica: active constituent of a new vaccine against infections caused by this pathogen.
Appl. Environ. Microbiol. 2018
doi: 10.1128/AEM.01877-17

María Emilia Gaillard, Daniela Bottero, María Eugenia Zurita, Francisco Carriquiriborde, Pablo Martin Aispuro, Erika Bartel, David Sabater-Martínez, María Sol Bravo, Celina Castuma, Daniela Flavia Hozbor.
Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.
Front. Immunol. 2017
doi: 10.3389/fimmu.2017.01099

Bergero PE, Fabricius G, Hozbor DF, Theeten H, Hens N.
Potential Impact of Changes in the Schedule for Primary DTP Immunization as Control Strategy for Pertussis.
Pediatr. Infect. Dis. J. 2017
doi: 10.1097/INF.0000000000001752

Bertona D, Pujato N, Bontempi I, Gonzalez V, Cabrera G, Gugliotta L, Hozbor D, Nicastro A, Calvinho L, Marcipar IS.
Development and assessment of a new cage-like particle adjuvant.
J. Pharm. Pharmacol. 2017
doi: 10.1111/jphp.12768

Hozbor DF.
Outer membrane vesicles: an attractive candidate for pertussis vaccines.
Expert Rev. Vaccines. 2016
doi: 10.1080/14760584.2017.1276832

Sisti F, Fernández J, Cordero A, Casabuono A, Couto A, Hozbor D.
Modifications of Bordetella bronchiseptica core lipopolysaccharide influence immune response without affecting protective activity.
Bioorg. Med. Chem. Lett. 2016
doi: 10.1016/j.bmcl.2016.12.049

Fallo AA, Neyro SE, Manonelles GV, Lara C, Hozbor D, Zintgraff J, Mazzeo S, Davison HE, González S, Zapulla E, Canle O, Huespe M, Galas M, López EL.
Prevalence of Pertussis Antibodies in Maternal Blood, Cord Serum, and Infants From Mothers With and Those Without Tdap Booster Vaccination During Pregnancy in Argentina.
J. Pediatric Infect. Dis. Soc. 2016
doi: 10.1093/jpids/piw069

Carbonetti NH, Wirsing von König CH, Lan R, Jacob-Dubuisson F, Cotter PA, Deora R, Merkel TJ, van Els CA, Locht C, Hozbor D, Rodriguez ME.
Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development.
Clin. Vaccine Immunol. Volume 23(11):842–850 – 2016

Henri Bailon Calderon, Nancy León Janampa, Carlos Padilla Rojas, Daniela Hozbor.
Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.
BMC Infect. Dis. Volume 16(1):422 – 2016
doi: 10.1186/s12879-016-1743-y

Bottero D, Gaillard ME, Zurita E, Moreno G, Sabater Martinez D, Bartel E, Bravo S, Carriquiriborde F, Errea A, Castuma C, Rumbo M, Hozbor D.
Characterization of the immune response induced by pertussis OMVs-based vaccine.
Vaccine. Volume 34(28):3303–3309 – 2016
doi: 10.1016/j.vaccine.2016.04.079

Fingermann M, Hozbor D.
Acid tolerance response of Bordetella bronchiseptica in avirulent phase.
Microbiological Research. Volume 181: 52–60 – 2015

Gaillard M, Bottero D, Moreno G, Rumbo M, Hozbor D.
Strategies and new developments to control pertussis, an actual health problem.
Pathogens and Disease. 2015

Pesco P, Bergero P, Fabricius G, Hozbor D.
Mathematical modeling of delayed pertussis vaccination in infants.
Vaccine. Volume 33(41):5475–5480 – 2015
doi: 10.1016/j.vaccine.2015.07.005

Tan T, Dalby T, Forsyth K, Halperin SA, Heininger U, Hozbor D, Plotkin S, Ulloa-Gutierrez R, von König CH.
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000–2013.
Pediatr. Infect. Dis. J. Volume 34(9): e222-e232 – 2015
doi: 10.1097/INF.0000000000000795

Errea A, González Maciel D, Hiriart Y, Hozbor D, Rumbo M.
Intranasal administration of TLR agonists induces a discriminated local innate response along murine respiratory tract.
Immunol. Lett. 2015
doi: 10.1016/j.imlet.2015.01.004

Maximiliano Ormazábal, Erika Bartel, María Emilia Gaillard, Daniela Bottero, Agustina Errea, M. Eugenia Zurita, Griselda Moreno, Martin Rumbo, Celina Castuma, Dario Flores, María Julia Martín, Daniela Hozbor.
Characterization of the key antigenic components of pertussis vaccine based on outer membrane vesicles.
Vaccine. Volume 32(46): 6084–6090 – 2014
doi: 10.1016/j.vaccine.2014.08.084

Luiza Helena Falleiros Arlant, Agustín de Colsa, Dario Flores, José Brea, Maria L. Avila Aguero, Daniela Hozbor.
Pertussis in Latin America: Epidemiology and Control Strategies.
Expert Rev. Anti Infect. Ther. Volume 12(10): 1265–1275 – 2014
doi: 10.1586/14787210.2014.948846

Viviana Romanin, Vanina Agustinho, Sandra Sagradini, Analía Aquino, María del Valle Juárez, Julián Antman, Carlos Giovacchini, Marcelo Galas, Claudia Lara, Daniela Hozbor, Ángela Gentile, Carla Vizzotti.
Situación epidemiológica de coqueluche y estrategias para su control. Argentina, 2002–2011.
Arch. Argent. Pediatr. Volume 112(5): 413–420 – 2014
doi: 10.1590/S0325-00752014000500005

Fallo A, Manonelles G, Hozbor D, Lara C, Huespe M, Mazzeo S, Canle O, Galas M, López E.
Pertussis seroprevalence in adults, post-partum women and umbilical cord blood.
Arch. Argent. Pediatr. Volume 112(4): 315–322 – 2014

Rumbo M, Hozbor D.
Development of improved pertussis vaccines.
Hum. Vaccin. Immunother. Volume 10(8) – 2014

Noelia Olivera, Celina E. Castuma, Daniela Hozbor, María E. Gaillard, Martín Rumbo, Ricardo M. Gómez.
Immunization with the Recombinant Cholera Toxin B Fused to Fimbria 2 Protein Protects against Bordetella pertussis Infection.
BioMed Research International. Volume 2014 – Article ID 421486 – 2014

Bottero D, Gaillard ME, Errea A, Moreno G, Zurita E, Pianciola L, Rumbo M, Hozbor D.
Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
Vaccine. Volume 31(45): 5262–5268 – 2013
doi: 10.1016/j.vaccine.2013.08.059

Griselda Moreno, Agustina Errea, Laurye Van Maele, Roy Roberts, Hélène Léger, Jean Claude Sirard, Arndt Benecke, Martin Rumbo, Daniela Hozbor.
Toll-like receptor 4 orchestrates neutrophil recruitment into airways during the first hours of Bordetella pertussis infection.
Microbes Infect. Volume 15(10-11): 708–718 – 2013
doi: 10.1016/j.micinf.2013.06.010

Pesco P, Bergero P, Fabricius G, Hozbor D.
Assessment of pertussis vaccination strategies using a mathematical model of disease transmission.
Arch. Argent. Pediatr. Volume 111(5): 377–383 – 2013
doi: 10.1590/S0325-00752013000500004

Eugenia Zurita, Griselda Moreno, Agustina Errea, Maximiliano Ormazabal, Martin Rumbo, Daniela Hozbor.
Stimulated innate resistance event (StIR) in Bordetella pertussis infection is dependent on reactive oxygen species production.
Infect. Immun. Volume 81(7): 2371–2378 – 2013
doi: 10.1128/IAI.00336-13

Sisti F, Ha DG, O'Toole GA, Hozbor DF, Fernandez J.
Cyclic-Di-GMP signaling regulates motility and biofilm formation in Bordetella bronchiseptica.
Microbiology. 2013

G. Fabricius, P. Bergero, M. Ormazabal, A. Maltz, D. Hozbor.
Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina.
Epidemiol. Infect. Volume 141(4): 718–734 – 2013
doi: 10.1017/S0950268812001380

Bottero D, Griffith MM, Lara C, Flores D, Pianciola L, Gaillard ME, Mazzeo M, Zamboni MI, Spoleti MJ, Anchart E, Ruggeri D, Sorhouet C, Fiori S, Galas M, Tondella ML, Hozbor D.
Bordetella holmesii in children suspected of pertussis in Argentina.
Epidemiol. Infect. Volume 141(4): 714–717 – 2013

Van der Ark AA, Hozbor DF, Boog CJ, Metz B, van den Dobbelsteen GP, van Els CA.
Resurgence of pertussis calls for re-evaluation of pertussis animal models.
Expert Rev. Vaccines. 2012
doi: 10.1586/erv.12.83

Bottero D, Gaillard M, Basile L, Fritz M, Hozbor D.
Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America.
J. Appl. Microbiol. Volume 112(6): 1266–1276 – 2012
doi: 10.1111/j.1365-2672.2012.05299.x

Lopardo H, Ruvinsky S, Casimir L, Bologna R, Mecikovsky D, Hozbor D.
Fatal laryngotracheitis caused by Bordetella bronchiseptica in a girl with AIDS.
J. Pediatr. Infect. Dis. Volume 6(2) – 2011

Sisti F, Fernández J, Higgins S, Cassabuono A, Couto A, Mills K, Hozbor D.
A deep rough type structure in Bordetella bronchiseptica lipopolysaccharide modulates host immune responses.
Microbiol. Immunol. Volume 55: 847–854 – 2011
doi: 10.1111/j.1348-0421.2011.00395.x

Gaillard ME, Bottero D, Castuma CE, Basile LA, Hozbor D.
Laboratory adaptation of Bordetella pertussis is associated with the loss of Type Three Secretion System functionality.
Infect. Immun. 2011

Asensio C, Moreno G, Gaillard ME, Bottero D, Zurita E, Rumbo M, van der Ley P, van der Ark A, Hozbor D.
Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.
Vaccine. Volume 29: 1649–1656 – 2011

Ulloa-Gutierrez R, Hozbor D, Avila-Aguero ML, Caro J, König CH, Tan T, Plotkin S.
The Global Pertussis Initiative: Meeting report from the regional Latin America meeting, Costa Rica, 5–6 December 2008.
Hum. Vaccin. Volume 6(11) – 2010

Pianciola L, Mazzeo M, Flores D, Hozbor D.
Optimization of processing and storage of clinical samples to be used for the molecular diagnosis of pertussis.
Rev. Argent. Microbiol. Volume 42(2): 108–113 – 2010

Hozbor DF, Gaillard ME, Lagares A, Yantorno OM.
Structural and functional characterization of biofilms formed by Bordetella bronchiseptica.
Microbiology. Volume 156: 1789–1799 – 2010

Hozbor DF.
BOOK CHAPTER: Pertussis: Pathogenesis and Immunity.
In: Bordetella: Molecular Microbiology, Locht C (ed.). Horizon Scientific Press, Norfolk, UK – 2016

Hozbor DF.
BOOK CHAPTER: Vaccines Based on Outer Membrane Vesicles: Application to Bordetella pertussis.
In: Vaccine Design: Methods and Protocols, Volume 3 – Resources for Vaccine Design. Series: Methods in Molecular Biology vol 1404, Springer – Humana Press – 2016
doi: 10.1007/978-1-4939-3389-1_9

Gaillard ME, Hozbor D.
BOOK CHAPTER: The Use of the Neonatal Mouse Model for the Study of Pertussis Vaccines.
In: Bordetella: Molecular Microbiology, Locht C (ed.). Horizon Scientific Press, Norfolk – 2016

Hozbor D.
BOOK CHAPTER: Vaccines: Acellular, Whole-Cell and Other Strategies for Pertussis Control.
In: Pertussis: Epidemiology, Immunology and Evolution, Elsevier – 2015

Hozbor DF.
BOOK CHAPTER: Molecular Basis of Bordetella Pathogenesis and Implications for Vaccine Design.
In: Bacterial Pathogenesis, Springer Verlag – 2014

Ministerio de Salud de la Nación Argentina.
TECHNOLOGICAL AND TECHNICAL PUBLICATIONS: Tutorial para notificación de Coqueluche a través de SIVILA.
Documento técnico. Septiembre – 2010

Ministerio de Salud de la Nación Argentina.
TECHNOLOGICAL AND TECHNICAL PUBLICATIONS: Actualización de Recomendaciones para las Infecciones Respiratorias Agudas.
Guía técnica oficial. Junio – 2012

Ministerio de Salud de la Nación Argentina.
TECHNOLOGICAL AND TECHNICAL PUBLICATIONS: Recomendaciones ante situación de Brote de Coqueluche.
Informe técnico. Agosto – 2012

Ver documento oficial (PDF)

Hozbor D.
DISCLOSURE DOCUMENTS: Pertussis, una enfermedad inmunoprevenible vigente.
Episteme. Revista de Ciencias, Instituto de Física La Plata – CONICET. Año 4 Nº 11: 18–20 – 2011

Hozbor D, Flores D, Bottero D, Lara C, Fiori S, Sorhouet C, Regueira M, Galas M, Venuta ME, Lopardo H.
DISCLOSURE DOCUMENTS: Vigilancia nacional de tos convulsa, coqueluche o pertussis: Experiencia del Hospital Garrahan y de los Laboratorios Nacionales de Referencia.
Revista Medicina Infantil. Número 4, Volumen XVII: 366 – 2010